trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['breast', 't-dxd']
t-dxd for patients with her2-low metastatic breast cancer patient-reported outcomes (pro) - the asco post desitny breeast-04 presentation at #esmo22 
MD Anderson Cancer Ctr, Breast Med Oncologist, Section Chief of Translational Breast Cancer Research, Executive Director of IBC Program